A Vision for Change: Exploring Biosimilars in Retinal Disease Management Eye on Ocular Health

    • Science

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA

Guest: Arghavan Almony, MD



The production of biosimilar therapies is setting the stage for a shift in how we approach treating patients with wet AMD, diabetic retinopathy, macular edema, and other retinal diseases, but many questions remain regarding how their efficacy and safety compare to the reference products and how we can best talk to our patients about these treatment options. To help shed light on these and other FAQs, Dr. Mary Katherine Cheeley speaks with Dr. Arghavan Almony, Adjunct Assistant Professor at Wallace School of Osteopathic Medicine at Campbell University in North Carolina.

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA

Guest: Arghavan Almony, MD



The production of biosimilar therapies is setting the stage for a shift in how we approach treating patients with wet AMD, diabetic retinopathy, macular edema, and other retinal diseases, but many questions remain regarding how their efficacy and safety compare to the reference products and how we can best talk to our patients about these treatment options. To help shed light on these and other FAQs, Dr. Mary Katherine Cheeley speaks with Dr. Arghavan Almony, Adjunct Assistant Professor at Wallace School of Osteopathic Medicine at Campbell University in North Carolina.

Top Podcasts In Science

Hidden Brain
Hidden Brain, Shankar Vedantam
Radiolab
WNYC Studios
Something You Should Know
Mike Carruthers | OmniCast Media | Cumulus Podcast Network
Making Sense with Sam Harris
Sam Harris
Tooth & Claw: True Stories of Animal Attacks
Wes Larson, Jeff Larson, Mike Smith | QCODE
Ologies with Alie Ward
Alie Ward

More by ReachMD